The Lancet: April 06, 2007

Dr Erika Sims from the University of East Anglia, UK, discusses the research article in this week's issue showing how newborn screening for cystic fibrosis is justifiable in economic terms, building on previous evidence showing the clinical value of newborn screening. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube....